Filter

Refine by date

—

Refine by collections

Refine by access

  • Print
  • Save

Search Results

You are looking at 61 - 70 of 327 items for :

  • "glucagon-like peptide-1" x
  • Refine by access: All content x
Clear All
Shin Tsunekawa Department of Endocrinology and Diabetes, School of Medicine, Nagoya University, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan
Central Research Laboratory, Sanwa Kagaku Kenkyusho Co. Ltd, 363 Shiosaki, Hokusei, Inabe, Mie 511-0406, Japan
Department of Pharmacology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan

Search for other papers by Shin Tsunekawa in
Google Scholar
PubMed Close
,
Naoki Yamamoto Department of Endocrinology and Diabetes, School of Medicine, Nagoya University, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan
Central Research Laboratory, Sanwa Kagaku Kenkyusho Co. Ltd, 363 Shiosaki, Hokusei, Inabe, Mie 511-0406, Japan
Department of Pharmacology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan

Search for other papers by Naoki Yamamoto in
Google Scholar
PubMed Close
,
Katsura Tsukamoto Department of Endocrinology and Diabetes, School of Medicine, Nagoya University, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan
Central Research Laboratory, Sanwa Kagaku Kenkyusho Co. Ltd, 363 Shiosaki, Hokusei, Inabe, Mie 511-0406, Japan
Department of Pharmacology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan

Search for other papers by Katsura Tsukamoto in
Google Scholar
PubMed Close
,
Yuji Itoh Department of Endocrinology and Diabetes, School of Medicine, Nagoya University, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan
Central Research Laboratory, Sanwa Kagaku Kenkyusho Co. Ltd, 363 Shiosaki, Hokusei, Inabe, Mie 511-0406, Japan
Department of Pharmacology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan

Search for other papers by Yuji Itoh in
Google Scholar
PubMed Close
,
Yukiko Kaneko Department of Endocrinology and Diabetes, School of Medicine, Nagoya University, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan
Central Research Laboratory, Sanwa Kagaku Kenkyusho Co. Ltd, 363 Shiosaki, Hokusei, Inabe, Mie 511-0406, Japan
Department of Pharmacology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan

Search for other papers by Yukiko Kaneko in
Google Scholar
PubMed Close
,
Toshihide Kimura Department of Endocrinology and Diabetes, School of Medicine, Nagoya University, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan
Central Research Laboratory, Sanwa Kagaku Kenkyusho Co. Ltd, 363 Shiosaki, Hokusei, Inabe, Mie 511-0406, Japan
Department of Pharmacology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan

Search for other papers by Toshihide Kimura in
Google Scholar
PubMed Close
,
Yoh Ariyoshi Department of Endocrinology and Diabetes, School of Medicine, Nagoya University, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan
Central Research Laboratory, Sanwa Kagaku Kenkyusho Co. Ltd, 363 Shiosaki, Hokusei, Inabe, Mie 511-0406, Japan
Department of Pharmacology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan

Search for other papers by Yoh Ariyoshi in
Google Scholar
PubMed Close
,
Yoshitaka Miura Department of Endocrinology and Diabetes, School of Medicine, Nagoya University, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan
Central Research Laboratory, Sanwa Kagaku Kenkyusho Co. Ltd, 363 Shiosaki, Hokusei, Inabe, Mie 511-0406, Japan
Department of Pharmacology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan

Search for other papers by Yoshitaka Miura in
Google Scholar
PubMed Close
,
Yutaka Oiso Department of Endocrinology and Diabetes, School of Medicine, Nagoya University, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan
Central Research Laboratory, Sanwa Kagaku Kenkyusho Co. Ltd, 363 Shiosaki, Hokusei, Inabe, Mie 511-0406, Japan
Department of Pharmacology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan

Search for other papers by Yutaka Oiso in
Google Scholar
PubMed Close
, and
Ichiro Niki Department of Endocrinology and Diabetes, School of Medicine, Nagoya University, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan
Central Research Laboratory, Sanwa Kagaku Kenkyusho Co. Ltd, 363 Shiosaki, Hokusei, Inabe, Mie 511-0406, Japan
Department of Pharmacology, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan

Search for other papers by Ichiro Niki in
Google Scholar
PubMed Close

Introduction The beneficial effects of glucagon-like peptide 1 (GLP-1) and its related substances such as inhibitors of dipeptidyl peptidase IV, its degrading enzyme, on the pancreatic β-cells have been reported; these agents enhance

Article Type:
Research Article
DOI:
https://doi.org/10.1677/JOE-06-0148
Volume/Issue:
Volume 193: Issue 1
Free access
S J Brandt Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
German Center for Diabetes Research (DZD), Neuherberg, Germany

Search for other papers by S J Brandt in
Google Scholar
PubMed Close
,
M Kleinert Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
German Center for Diabetes Research (DZD), Neuherberg, Germany

Search for other papers by M Kleinert in
Google Scholar
PubMed Close
,
M H Tschöp Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
German Center for Diabetes Research (DZD), Neuherberg, Germany
Division of Metabolic Diseases, Technische Universität, Munich, Germany

Search for other papers by M H Tschöp in
Google Scholar
PubMed Close
, and
T D Müller Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
German Center for Diabetes Research (DZD), Neuherberg, Germany

Search for other papers by T D Müller in
Google Scholar
PubMed Close

). For example, following Roux-en-Y gastric bypass, gastric banding or sleeve gastronomy, there is an increase in the secretion of glucagon-like peptide 1 (GLP-1) ( Laferrere 2016 , Meek et al. 2016 , Clemmensen et al. 2017 ), which is known not

Article Type:
Review Article
DOI:
https://doi.org/10.1530/JOE-18-0264
Volume/Issue:
Volume 238: Issue 2
Open access
Berit Svendsen Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark

Search for other papers by Berit Svendsen in
Google Scholar
PubMed Close
,
Ramona Pais Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark

Search for other papers by Ramona Pais in
Google Scholar
PubMed Close
,
Maja S Engelstoft Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark

Search for other papers by Maja S Engelstoft in
Google Scholar
PubMed Close
,
Nikolay B Milev Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark

Search for other papers by Nikolay B Milev in
Google Scholar
PubMed Close
,
Paul Richards Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark

Search for other papers by Paul Richards in
Google Scholar
PubMed Close
,
Charlotte B Christiansen Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark

Search for other papers by Charlotte B Christiansen in
Google Scholar
PubMed Close
,
Kristoffer L Egerod Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark

Search for other papers by Kristoffer L Egerod in
Google Scholar
PubMed Close
,
Signe M Jensen Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark

Search for other papers by Signe M Jensen in
Google Scholar
PubMed Close
,
Abdella M Habib Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark

Search for other papers by Abdella M Habib in
Google Scholar
PubMed Close
,
Fiona M Gribble Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark

Search for other papers by Fiona M Gribble in
Google Scholar
PubMed Close
,
Thue W Schwartz Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark

Search for other papers by Thue W Schwartz in
Google Scholar
PubMed Close
,
Frank Reimann Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark

Search for other papers by Frank Reimann in
Google Scholar
PubMed Close
, and
Jens J Holst Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Wellcome Trust – MRC Institute of Metabolic Science, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark

Search for other papers by Jens J Holst in
Google Scholar
PubMed Close

Introduction The incretin hormones, glucagon-like peptide-1 (GLP1) and glucose-dependent insulinotropic polypeptide (GIP) strongly potentiate postprandial insulin secretion and are therefore important regulators of glucose homeostasis. They are

Article Type:
Research Article
DOI:
https://doi.org/10.1530/JOE-15-0247
Volume/Issue:
Volume 228: Issue 1
Free access
Jordan S F Chan Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada

Search for other papers by Jordan S F Chan in
Google Scholar
PubMed Close
,
Tanin Shafaati Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada

Search for other papers by Tanin Shafaati in
Google Scholar
PubMed Close
, and
John R Ussher Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada
Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada

Search for other papers by John R Ussher in
Google Scholar
PubMed Close

approval of three new drug classes available for the treatment of T2D, including the glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) agonists, the dipeptidyl peptidase-4 (DPP-4) inhibitors, and the sodium–glucose co-transporter 2 inhibitors. Although

Article Type:
Review Article
DOI:
https://doi.org/10.1530/JOE-24-0011
Volume/Issue:
Volume 263: Issue 1
Restricted access
Erica Yeo Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada
Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada

Search for other papers by Erica Yeo in
Google Scholar
PubMed Close
,
Patricia L Brubaker Department of Physiology, University of Toronto, Toronto, ON, Canada
Department of Medicine, University of Toronto, Toronto, ON, Canada

Search for other papers by Patricia L Brubaker in
Google Scholar
PubMed Close
, and
Deborah M Sloboda Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada
Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada
Department of Obstetrics, Gynecology and Pediatrics, McMaster University, Hamilton, ON, Canada

Search for other papers by Deborah M Sloboda in
Google Scholar
PubMed Close

secretion, appetite regulation and gut motility) ( Gibbs et al. 1997 , Suzuki et al. 2010 ). However, of all the potential endocrine factors that could contribute to maternal metabolic adaptations to pregnancy, glucagon-like peptide-1 (GLP-1) is

Article Type:
Review Article
Collections:
Gut microbiome special collection
DOI:
https://doi.org/10.1530/JOE-21-0354
Volume/Issue:
Volume 253: Issue 1
Open access
Eun-Young Lee Department of Medical Physiology, Chiba University, Graduate School of Medicine, Chiba, Japan

Search for other papers by Eun-Young Lee in
Google Scholar
PubMed Close
,
Xilin Zhang Department of Medical Physiology, Chiba University, Graduate School of Medicine, Chiba, Japan

Search for other papers by Xilin Zhang in
Google Scholar
PubMed Close
,
Junki Miyamoto Department of Applied Biological Science, Graduate School of Agriculture, Tokyo University of Agriculture and Technology, Fuchu, Japan

Search for other papers by Junki Miyamoto in
Google Scholar
PubMed Close
,
Ikuo Kimura Department of Applied Biological Science, Graduate School of Agriculture, Tokyo University of Agriculture and Technology, Fuchu, Japan

Search for other papers by Ikuo Kimura in
Google Scholar
PubMed Close
,
Tomoaki Taknaka Department of Molecular Diagnosis, Chiba University, Graduate School of Medicine, Chiba, Japan

Search for other papers by Tomoaki Taknaka in
Google Scholar
PubMed Close
,
Kenichi Furusawa Drug Fostering and Evolution Coordinating Center, Sanwa Kagaku Kenkyusho Co., Ltd., Nagoya, Japan

Search for other papers by Kenichi Furusawa in
Google Scholar
PubMed Close
,
Takahito Jomori Drug Fostering and Evolution Coordinating Center, Sanwa Kagaku Kenkyusho Co., Ltd., Nagoya, Japan

Search for other papers by Takahito Jomori in
Google Scholar
PubMed Close
,
Kosuke Fujimoto Department of Mucosal Immunology, Chiba University, Graduate School of Medicine, Chiba, Japan
Division of Innate Immune Regulation, International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, The University of Tokyo, Minato-ku, Japan

Search for other papers by Kosuke Fujimoto in
Google Scholar
PubMed Close
,
Satoshi Uematsu Department of Mucosal Immunology, Chiba University, Graduate School of Medicine, Chiba, Japan
Division of Innate Immune Regulation, International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, The University of Tokyo, Minato-ku, Japan

Search for other papers by Satoshi Uematsu in
Google Scholar
PubMed Close
, and
Takashi Miki Department of Medical Physiology, Chiba University, Graduate School of Medicine, Chiba, Japan

Search for other papers by Takashi Miki in
Google Scholar
PubMed Close

Introduction Oral ingestion of carbohydrate triggers secretion of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), the major incretins that inhibit the rise in blood glucose levels by potentiating insulin

Article Type:
Research Article
DOI:
https://doi.org/10.1530/JOE-18-0241
Volume/Issue:
Volume 239: Issue 3
Restricted access
Tianru Jin Departments of Medicine, Division of Cell and Molecular Biology, Physiology, and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Departments of Medicine, Division of Cell and Molecular Biology, Physiology, and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Tianru Jin in
Google Scholar
PubMed Close

cDNAs from these species further revealed that it encodes not only glucagon but also two glucagon-like peptide hormones, namely glucagon-like peptide-1 (GLP-1) and GLP-2 ( Lund et al . 1982 ). Glucagon is produced and released from the pancreatic α

Article Type:
Research Article
DOI:
https://doi.org/10.1677/JOE-08-0085
Volume/Issue:
Volume 198: Issue 1
Free access
N M Whalley Faculty of Medical and Human Sciences, Faculty of Life Sciences, Diabetes Research Group, Manchester Academic Health Sciences Centre, University of Manchester, 3.016 AV Hill Building, Manchester M13 9PT, UK
Faculty of Medical and Human Sciences, Faculty of Life Sciences, Diabetes Research Group, Manchester Academic Health Sciences Centre, University of Manchester, 3.016 AV Hill Building, Manchester M13 9PT, UK

Search for other papers by N M Whalley in
Google Scholar
PubMed Close
,
L E Pritchard Faculty of Medical and Human Sciences, Faculty of Life Sciences, Diabetes Research Group, Manchester Academic Health Sciences Centre, University of Manchester, 3.016 AV Hill Building, Manchester M13 9PT, UK

Search for other papers by L E Pritchard in
Google Scholar
PubMed Close
,
D M Smith Faculty of Medical and Human Sciences, Faculty of Life Sciences, Diabetes Research Group, Manchester Academic Health Sciences Centre, University of Manchester, 3.016 AV Hill Building, Manchester M13 9PT, UK

Search for other papers by D M Smith in
Google Scholar
PubMed Close
, and
A White Faculty of Medical and Human Sciences, Faculty of Life Sciences, Diabetes Research Group, Manchester Academic Health Sciences Centre, University of Manchester, 3.016 AV Hill Building, Manchester M13 9PT, UK
Faculty of Medical and Human Sciences, Faculty of Life Sciences, Diabetes Research Group, Manchester Academic Health Sciences Centre, University of Manchester, 3.016 AV Hill Building, Manchester M13 9PT, UK

Search for other papers by A White in
Google Scholar
PubMed Close

. doi:10.1002/rcm.3253 . Buteau J El-Assaad W Rhodes CJ Rosenberg L Joly E Prentki M 2004 Glucagon-like peptide-1 prevents beta cell glucolipotoxicity . Diabetologia 47 806 – 815 . doi:10.1007/s00125-004-1379-6 . Chu ZL Jones RM

Article Type:
Research Article
DOI:
https://doi.org/10.1530/JOE-11-0094
Volume/Issue:
Volume 211: Issue 1
Free access
Elizabeth M Simpson School of Agricultural, Environmental and Veterinary Sciences, Faculty of Science and Health, Charles Sturt University, Wagga Wagga, NSW, Australia
Gulbali Institute, Charles Sturt University, Wagga Wagga, NSW, Australia

Search for other papers by Elizabeth M Simpson in
Google Scholar
PubMed Close
,
Iain J Clarke School of Agriculture Food and Ecosystem Sciences, Faculty of Science, The University of Melbourne, Parkville, VIC, Australia

Search for other papers by Iain J Clarke in
Google Scholar
PubMed Close
,
Christopher J Scott School of Dentistry and Medical Science, Faculty of Science and Health, Charles Sturt University, Wagga Wagga, NSW, Australia

Search for other papers by Christopher J Scott in
Google Scholar
PubMed Close
,
Cyril P Stephen School of Agricultural, Environmental and Veterinary Sciences, Faculty of Science and Health, Charles Sturt University, Wagga Wagga, NSW, Australia
Gulbali Institute, Charles Sturt University, Wagga Wagga, NSW, Australia

Search for other papers by Cyril P Stephen in
Google Scholar
PubMed Close
,
Alexandra Rao School of Agriculture Food and Ecosystem Sciences, Faculty of Science, The University of Melbourne, Parkville, VIC, Australia

Search for other papers by Alexandra Rao in
Google Scholar
PubMed Close
, and
Allan J Gunn School of Agricultural, Environmental and Veterinary Sciences, Faculty of Science and Health, Charles Sturt University, Wagga Wagga, NSW, Australia
Gulbali Institute, Charles Sturt University, Wagga Wagga, NSW, Australia

Search for other papers by Allan J Gunn in
Google Scholar
PubMed Close

OVX ewes ( Iqbal et al. 2006 ). Another circulating appetite-regulating peptide is glucagon-like peptide 1 (GLP-1) encoded by the preproglucagon gene ( GCG ) ( Huda et al. 2006 , Sandoval & D'Alessio 2015 , Sekar 2017 ). GLP-1 is an anorexigen

Article Type:
Research Article
DOI:
https://doi.org/10.1530/JOE-23-0105
Volume/Issue:
Volume 259: Issue 1
Open access
Yingxin Xian Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China

Search for other papers by Yingxin Xian in
Google Scholar
PubMed Close
,
Zonglan Chen Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China

Search for other papers by Zonglan Chen in
Google Scholar
PubMed Close
,
Hongrong Deng Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China

Search for other papers by Hongrong Deng in
Google Scholar
PubMed Close
,
Mengyin Cai Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China

Search for other papers by Mengyin Cai in
Google Scholar
PubMed Close
,
Hua Liang Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China

Search for other papers by Hua Liang in
Google Scholar
PubMed Close
,
Wen Xu Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China

Search for other papers by Wen Xu in
Google Scholar
PubMed Close
,
Jianping Weng Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China

Search for other papers by Jianping Weng in
Google Scholar
PubMed Close
, and
Fen Xu Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China

Search for other papers by Fen Xu in
Google Scholar
PubMed Close

visceral omental fat in subjects with obesity exhibit severely impaired endothelium-dependent vasodilation ( Farb et al. 2012 ). Clinical studies demonstrated that exenatide, a glucagon-like peptide 1 (GLP-1) receptor agonist, improved glycemic control

Article Type:
Research Article
DOI:
https://doi.org/10.1530/JOE-18-0639
Volume/Issue:
Volume 242: Issue 2
Free access